Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients
about
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancerCD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis.Increased expression of interleukin-23 associated with progression of colorectal cancer.Interleukin-23 as a therapeutic target for inflammatory myopathy.
P2860
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@ast
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@en
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@nl
type
label
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@ast
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@en
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@nl
prefLabel
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@ast
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@en
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@nl
P2093
P2860
P50
P356
P1433
P1476
Investigation of IL-23 (p19, p ...... ticenter study of 675 patients
@en
P2093
Alessandro Lugli
Anne Lukesch
Beat Schnüriger
Eva Karamitopoulou
Heather Dawson
Inti Zlobec
Makhmud Mallaev
Mario Tschan
Marion Hädrich
Markus Borner
P2860
P304
P356
10.18632/ONCOTARGET.2069
P407
P577
2014-07-01T00:00:00Z